A detailed history of Trium Capital LLP transactions in Morpho Sys Ag stock. As of the latest transaction made, Trium Capital LLP holds 11,700 shares of MOR stock, worth $0. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,700
Holding current value
$0
% of portfolio
0.08%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Trium Capital LLP Portfolio

Follow Trium Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trium Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Trium Capital LLP with notifications on news.